Cyclopropylmethyl-(6,8-dimethyl-1H-pyrazolo[3',4':4,5]thieno[2,3-b]pyridin-3-yl)-amine

ID: ALA4559841

PubChem CID: 89445258

Max Phase: Preclinical

Molecular Formula: C14H16N4S

Molecular Weight: 272.38

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C)c2c(n1)sc1c(NCC3CC3)n[nH]c12

Standard InChI:  InChI=1S/C14H16N4S/c1-7-5-8(2)16-14-10(7)11-12(19-14)13(18-17-11)15-6-9-3-4-9/h5,9H,3-4,6H2,1-2H3,(H2,15,17,18)

Standard InChI Key:  JOIKEKVWSRWZOP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 19 22  0  0  0  0  0  0  0  0999 V2000
   34.1431  -23.7811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1420  -24.6006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8500  -25.0096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.8483  -23.3722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8458  -22.5550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5569  -23.7775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5571  -24.6006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3401  -24.8548    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   33.4340  -25.0086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3397  -23.5229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8288  -24.1897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6141  -23.9306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6104  -23.1036    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.8228  -22.8517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.2774  -24.4079    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.0225  -24.0722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7355  -24.4713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1529  -25.1704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.5521  -24.4573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  7  2  0
  6  4  2  0
  4  1  1  0
  4  5  1  0
  6  7  1  0
  7  8  1  0
  8 11  1  0
 10  6  1  0
  2  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 10  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 18 17  1  0
 19 18  1  0
 17 19  1  0
M  END

Associated Targets(Human)

CHRM4 Tclin Muscarinic acetylcholine receptor M4 (6041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 272.38Molecular Weight (Monoisotopic): 272.1096AlogP: 3.61#Rotatable Bonds: 3
Polar Surface Area: 53.60Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.55CX Basic pKa: 2.85CX LogP: 2.92CX LogD: 2.92
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.77Np Likeness Score: -1.65

References

1. Poslusney MS, Salovich JM, Wood MR, Melancon BJ, Bollinger KA, Luscombe VB, Rodriguez AL, Engers DW, Bridges TM, Niswender CM, Conn PJ, Lindsley CW..  (2019)  Novel M4 positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands.,  29  (3): [PMID:30580918] [10.1016/j.bmcl.2018.12.039]

Source